Skip to main content
Clinical Trials/NCT05615896
NCT05615896TerminatedNot Applicable

Data Collection With the P200TE and P200TxE in Diseased Eyes for Clinical Developments

Optos, PLC1 site in 1 country5 target enrollmentStarted: April 22, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Optos, PLC
Enrollment
5
Locations
1
Primary Endpoint
Collection of images

Study Overview

Brief Summary

The primary objective is to collect OCT scans on a modified P200TxE and P200TE.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
22 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Male or female volunteers 22 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed;
  • •Volunteers who can follow the instructions by the clinical staff at the clinical site;
  • •Volunteers who agree to participate;
  • •Volunteers who have been diagnosed with retina pathology with intra-retinal and/or subretinal fluid present in the posterior pole region.

Exclusion Criteria

  • •Volunteers unable to tolerate ophthalmic imaging;
  • •Volunteers with ocular media not sufficiently clear to obtain acceptable OCT images.

Arms & Interventions

P200TE Device First

Experimental

Intervention: Imaging Session (Device)

P200TxE Device First

Experimental

Intervention: Imaging Session (Device)

Outcomes

Primary Outcomes

Collection of images

Time Frame: 1 year

The primary endpoint will be the collection of OCT scans on the P200TE and P200TxE devices. The scans will be used by R\&D for development of a de-noising algorithm as well as other possible developments.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Optos, PLC
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials